S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Forget NVDA. Buy this A.I. stock instead (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
Tentative deal reached to end the Hollywood writers strike. No deal yet for actors
His system isolated NVIDIA - Here's His Next Buy. (Ad)
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Canadian autoworkers ratify new labor agreement with Ford
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
OTCMKTS:KALTF

Claritas Pharmaceuticals (KALTF) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
$0.00
▼
$0.08
52-Week Range
N/A
Volume
N/A
Average Volume
9,705 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlinesShort Interest

KALTF stock logo

About Claritas Pharmaceuticals (OTCMKTS:KALTF) Stock

Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.


KALTF Stock News Headlines

July 6, 2023 | finance.yahoo.com
DPHAY - Dechra Pharmaceuticals PLC
June 22, 2023 | marketwatch.com
Animal Health Active Pharmaceutical Ingredients Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2030
September 24, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
June 21, 2023 | finance.yahoo.com
ACXP - Acurx Pharmaceuticals, Inc.
April 27, 2023 | marketwatch.com
Pharmaceutical Lecithin Market Size, Growth, Outlook, Share, Segmentation Analysis, Revenue And Forecast 2031
March 17, 2023 | marketwatch.com
Generic Drugs Market Share, Segmentation and Forecast 2023-2028
February 14, 2023 | marketwatch.com
2023 Pharmaceutical CDMO Services Market Segmentation and Targeting: Strategies for Success Forecast till 2028
February 13, 2023 | marketwatch.com
2023 Mifepristone Market Segmentation and Targeting: Strategies for Success Forecast till 2028
September 24, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
January 19, 2023 | marketwatch.com
Radioimmunotherapy Treatment Market Geographical Segmentation By Forecast Revenue 2023-2028
January 12, 2023 | finance.yahoo.com
Claritas Pharmaceuticals, Inc. (CLAZF)
January 5, 2023 | marketwatch.com
Online Pharmaceuticals Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Data
November 30, 2022 | marketwatch.com
Analgesics Market Global Investor, Latest Trends, Industry Growth, Size, Segmentation, Future Demands, by Regional Forecast to 2028
September 30, 2022 | marketwatch.com
Pharmaceutical Sachet Market In 2022 : Industry Growth, Top Players, Segmentation and Forecast to 2028 with Top Countries Data
September 22, 2022 | finance.yahoo.com
New Claritas Report Reveals that the U.S. Hispanic Population Grew 89% Since 2000 – and Will Exceed 74 Million Consumers by 2028
September 13, 2022 | reuters.com
Claritas Pharmaceuticals Inc
May 11, 2022 | investing.com
Claritas Pharmaceuticals Inc (CLAS)
March 12, 2022 | benzinga.com
Kaya Now Appoints Stormy Simon As A Director Of The Board
February 22, 2022 | finance.yahoo.com
Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing
February 9, 2022 | finance.yahoo.com
Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022
January 26, 2022 | finance.yahoo.com
Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners
January 17, 2022 | finance.yahoo.com
Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns
January 17, 2022 | finance.yahoo.com
Claritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina Partners
January 12, 2022 | seekingalpha.com
Claritas Pharmaceuticals signs $5M equity financing deal
January 12, 2022 | finance.yahoo.com
Claritas Secures $5 Million Equity Financing Facility with Alumina Partners (Ontario) Ltd.
December 22, 2021 | finance.yahoo.com
Claritas to Develop R-107 for Treatment of PPHN, a Potentially Fatal Pulmonary Disorder in Newborns
December 21, 2021 | finance.yahoo.com
Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease
See More Headlines
Receive KALTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Claritas Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

KALTF Company Calendar

Last Earnings
11/29/2013
Today
9/24/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:KALTF
Previous Symbol
OTCMKTS:QUEZF
CUSIP
N/A
CIK
N/A
Web
kalytera.co
Phone
(888) 861-2008
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Robert Edward Farrell
    Chairman, President & Chief Executive Officer
  • Victoria Diana Rudman
    Chief Financial Officer, Secretary & Treasurer
  • Nedira Frenkel
    Director-Business Development

Key Competitors

View All Competitors













KALTF Stock - Frequently Asked Questions

How were Claritas Pharmaceuticals' earnings last quarter?

Claritas Pharmaceuticals, Inc. (OTCMKTS:KALTF) issued its quarterly earnings data on Friday, November, 29th. The company reported ($0.40) EPS for the quarter.

When did Claritas Pharmaceuticals' stock split?

Claritas Pharmaceuticals shares reverse split on the morning of Friday, July 23rd 2021. The 1-20 reverse split was announced on Friday, July 23rd 2021. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 23rd 2021. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Claritas Pharmaceuticals' stock symbol?

Claritas Pharmaceuticals trades on the OTCMKTS under the ticker symbol "KALTF."

How do I buy shares of Claritas Pharmaceuticals?

Shares of KALTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How can I contact Claritas Pharmaceuticals?

Claritas Pharmaceuticals' mailing address is 4040 Civic Center Drive, San Rafael, CA 94903. The official website for the company is kalytera.co. The company can be reached via phone at (888) 861-2008.

This page (OTCMKTS:KALTF) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -